EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) ON MYELOPOIESIS AND THROMBOPOIESIS OF RABBITS

The effects of recombinant human erythropoietin (rhEPO, Recormon(R), CAS 122312-54-3) on the differential leucocyte counts and platelets of rabbits were investigated after the repeated application of a single dose of rhEPO. Therefore, 150 IU rhEPO (n = 5), 300 IU rhEPO (n = 6), or 600 IU rhEPO (n = 5) per animal was injected once on three separate occasions with an interval of 5-6 weeks between each injection. Six animals were used to study the potential effect of the solvent alone. rhEPO showed a significant time effect on the differential leucocyte counts and platelets of rabbits. The decrease in total white blood cells count (WBC) on the third, fourth and sixth day after rhEPO administration was due to a decrease in lymphocytes. These results support the hypothesis that the enhanced demand of one cell line leads to a down-modulation of the production of other cell line(s).